Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-16

Clinical Trial Update: Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating sildenafil for urinary incontinence in patients with spinal cord injuries; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Spinal Cord Injuries, Urinary Incontinence | Phase 2 | Status: RECRUITING